A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD
Conditions: Von Willebrand Diseases Interventions: Drug: Lyophilized concentrate of human coagulation von Willebrand Factor and factor VIII; Other: Placebo Sponsors: Unity Health Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials

Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)
Conditions: Von Willebrand Disease (VWD) Interventions: Biological: TAK-577 Sponsors: Takeda Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials

Recombinant vWF Concentrate and ECMO
Conditions: Bleeding Disorder Interventions: Drug: Recombinant von Willebrand Factor Sponsors: University of Virginia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials

Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
Conditions: Cerebral Microbleeds, Congenital Haemophilia, Congenital Von Willebrand Disease Interventions: Other: 3-Tesla brain MRI and a comprehensive neuropsychological assessment Sponsors: University Hospital, Lille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials

To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.
Conditions: Acute on Chronic Liver Failure Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Von Willebrand Disease Patients
Conditions: Von Willebrand Disease, Type 1; Heavy Menstrual Bleeding Interventions: Device: Volta System Sponsors: Five Liters, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials

The Lived Experience of People With Von Willebrand Disease
Conditions: Von Willebrand Diseases Interventions: Other: Online Survey; Other: Qualitative Interview; Other: Bleed Diary Sponsors: Haemnet; Hemab Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials

Hematological Disorder in Patients With Angiodysplasia
Conditions: Angiodysplasia; Hematological Disease Interventions: Diagnostic Test: Von willebrand antigen Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease
Condition:   Von Willebrand Diseases Interventions:   Drug: VGA039;   Other: Placebo Sponsor:   Vega Therapeutics, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials